Premium
Drug Management of Fetal Tachyarrhythmias: Are We Ready for a Systematic and Evidence‐Based Approach?
Author(s) -
VAN DEN HEUVEL FREEK,
BINKBOELKENS MARGREET Th.E.,
SARVAAS GIDEON J. DU MARCHIE,
BERGER ROLF M.F.
Publication year - 2008
Publication title -
pacing and clinical electrophysiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.686
H-Index - 101
eISSN - 1540-8159
pISSN - 0147-8389
DOI - 10.1111/j.1540-8159.2008.00958.x
Subject(s) - medicine , drug , intensive care medicine , fetus , medline , pregnancy , pharmacology , political science , law , genetics , biology
Fetal tachyarrhythmias are a life‐threatening condition complicating a small proportion of normal pregnancies. Despite major advances in the (intrauterine) pharmacologic treatment of these arrhythmias over the last years major uncertainties remain. Among these are controversies in the choice of agents in relation to arrhythmia type, and timing and duration of treatment. Currently, no evidence‐based approach to the management of fetal tachyarrhythmias is available. An international registry is proposed as an important step toward obtaining the necessary data to develop evidence‐based management strategies.